Name: UMIN ID:
Unique ID issued by UMIN | UMIN000009086 |
---|---|
Receipt number | R000010278 |
Scientific Title | Cohort study evaluating efficacy of bevacizumab plus paclitaxel in patients with HER2-negative inoperable or metastatic breast cancer(JBCRG-C05) |
Date of disclosure of the study information | 2012/10/12 |
Last modified on | 2021/08/18 09:27:07 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2012/10/11 11:37:16 | ||
2 | Update | 2012/12/14 11:46:28 | Recruitment status |
|
3 | Update | 2013/06/17 16:45:48 | Acronym Acronym |
|
4 | Update | 2013/06/17 16:46:26 | Recruitment status |
|
5 | Update | 2014/04/30 15:51:07 | TEL |
|
6 | Update | 2016/07/08 15:38:14 | Recruitment status |
|
7 | Update | 2016/11/04 18:17:43 | Organization Organization Address Address TEL Name of primary person or sponsor Organization |
|
8 | Update | 2016/11/04 18:18:31 | Last follow-up date Publication of results |
|
9 | Update | 2018/08/24 10:06:39 | UMIN ID1 UMIN ID2 |
|
10 | Update | 2019/09/05 14:28:41 | Key exclusion criteria |
|
11 | Update | 2019/09/05 14:34:02 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Organization Zip code Address Address Last name of contact person Last name of contact person Zip code Address Address Organization Organization Organization Address Address Tel |
|
12 | Update | 2019/09/05 14:37:00 | Publication of results Number of participants that the trial has enrolled Results Delayed Results Delay Reason Results Delay Reason |
|
13 | Update | 2019/09/05 14:41:58 | Date of IRB |
|
14 | Update | 2021/07/15 14:13:02 | Last name of contact person Last name of contact person Division name Address Name of person sending information Name of person sending information Organization Organization Division name Division name Address Address TEL |
|
15 | Update | 2021/07/15 15:47:08 | Homepage URL |
|
16 | Update | 2021/08/05 17:47:26 | Recruitment status |
|
17 | Update | 2021/08/18 09:27:07 | URL releasing protocol Publication of results URL related to results and publications Results Results Results date posted Results Delayed Results Delay Reason Results Delay Reason Date of the first journal publication of results Baseline Characteristics Baseline Characteristics Participant flow Participant flow Adverse events Adverse events Outcome measures Outcome measures |